Pathology testing and Neuroendocrine tumours (NETs)

Similar documents
Neuroendocrine Tumors

Haemochromatosis. Testing and Treatment

Standard of care Inflammatory Bowel Disease (IBD)

Prostate Cancer Testing. Don t be caught out

Diagnosing and monitoring NET

Sandostatin LAR. Sandostatin LAR (octreotide acetate) Description

NeuroEndocrine Tumors Diagnostic and therapeutic challenges: introduction

Tumor markers. Chromogranin A. Analyte Information

Systemic Therapy for Gastroenteropancreatic (GEP) Neuroendocrine Tumors and Lung Carcinoid

GI CARCINOID Dr Mussawar Iqbal Consultant Oncologist Hull and East Yorkshire Hospitals NHS Trust

X-Plain Pancreatic Cancer Reference Summary

Tumour Markers. For these reasons, only a handful of tumour markers are commonly used by most doctors.

Allergies. and their diagnosis

EXOCRINE: 93% Acinar Cells Duct Cells. ENDOCRINE: 5% Alpha Cells Beta Cells Delta Cells Others

Gastrointestinal Neuroendocrine Tumors: A Closer Look at the Characteristics of These Diverse Tumors

Learning. A part of your guide to Neuroendocrine Tumours (NETs)

Fast, automated, precise

SOMATULINE AUTOGEL 60, 90 AND 120 mg

SOMATULINE AUTOGEL. What is in this leaflet? 60, 90 AND 120 mg. Lanreotide CONSUMER MEDICINE INFORMATION

Pancreatic Cancer Early Detection, Diagnosis, and Staging

Neuroendocrine Tumors: Just the Basics. George Fisher, MD PhD

Strategies in the Management of Neuroendocrine Tumors. Dr. Jean Maroun Dr. Elena Tsvetkova

Corporate Medical Policy

Rare GI Malignancies

Pancreatic Cancer (1 of 5)

Greater Manchester and Cheshire HPB Unit Guidelines for the Assessment & Management of Hepatobiliary and Pancreatic Disease Chapter 14

Chronic Pancreatitis (1 of 4) i

SCOPE TODAYS SESSION. Case 1: Case 2. Basic Theory Stuff: Heavy Stuff. Basic Questions. Basic Questions

Survivorship care of Neuroendocrine Tumours(NETs) from a Specialised Nursing Perspective

Treatment for early pancreatic cancer

Endocrinology and VHL: The adrenal and the pancreas

Control of Glucose Metabolism

This page explains some of the medical words that you may hear when you are finding out about pancreatic cancer and how it is treated.

system to help fight cancer Working with your immune

Appendix 4: WHO Classification of Tumours of the pancreas 17

Neuroendocrine Cancer

system to help fight cancer Working with your immune

Gastrinoma: Medical Management. Haley Gallup

What is Liver Cancer? About the Liver

NET und NEC. Endoscopic and oncologic therapy

Hypoglycemia. When recognized early, hypoglycemia can be treated successfully.

Q&A Session NAACCR Webinar Series Collecting Cancer Data: Pancreas January 05, 2012

AN ARGUMENT FOR SURGERY FOR GASTRINOMA. Lauren Wilson R1 General Surgery

The incidence of pancreatic cancer is rising in India and is higher in the urban male population in the western and northern parts of India.

Neuroendocrine Tumours (NETs) - Treatment Pathway Toolkit. See inside for further information on rarer types of NETs

THE WHIPPLE PROCEDURE

Pancreatic Cancer Treatment

64a Pathology: Digestive System!

Neuroendocrine Tumors

Color Codes Pathology and Genetics Medicine and Clinical Pathology Surgery Imaging

Bio& 242 Unit 1 / Lecture 4

(A) Diarrhea. (B) Stomach cramps. (C) Dehydration due to excess fluid loss. (D) A, B, and C are correct. (E) Only answer B is correct.

FRANKLY SPEAKING ABOUT CANCER: NEUROENDOCRINE & CARCINOID TUMORS (NETS)

Patient Experience Survey

How does the form of the digestive system help it with its function?

Biology 12 - Digestion Notes

RABEPRAZOL 10mg and 20mg Gastro-resistant Tablets

Pancreatitis. Acute Pancreatitis

An Overview of NETS. Richard R.P. Warner M.D

Colonoscopy Explained

Endocrine System WHO IS IN CONTROL?

Nonalcoholic Steatohepatitis National Digestive Diseases Information Clearinghouse

Learning Targets. The Gastrointestinal (GI) Tract. Also known as the alimentary canal. Hollow series of organs that food passes through

Your Medical Details and Treatment Tracker. About You

Information for people affected by Lung NETs

Quick Facts about Ampullary Cancer

PNET 3/7/2015. GI and Pancreatic NETs. The Postgraduate Course in Breast and Endocrine Surgery. Decision Tree. GI and Pancreatic NETs.

NHS Training for Physiotherapy Support Workers. Workbook 13 The digestive system

Joy E.S. Ardill, PhD, MRCPath a, Thomas M. O Dorisio, MD b, *

Station 1. Identify (= name) the spaces or structures labeled 1 9.

Quick Facts about Bile Duct Cancer

Table: CPT Codes / HCPCS Codes / ICD - 10 Codes ; Code Code Description; Information in the [brackets] below has been added for clarification

Ebele C. Chira, MD 1055 Clarksville Street, Suite 190, Paris, TX Phone (903) Fax (903)

Digestion Review V1 /36

Zollinger-Ellison Syndrome

Management of Pancreatic Islet Cell Tumors

PACKAGE LEAFLET: INFORMATION FOR THE USER

Carcinoid Tumors: The Beginning and End. Surgical Oncology Update 2011 Chris Baliski MD, FRCS BC Cancer Agency, CSI October 21, 2011

Evaluation of Suspected Pancreatic Cancer

Hepatobiliary investigations

Gastrointestinal Carcinoid Tumor Early Detection, Diagnosis, and Staging

DOWNLOAD PDF TUMORS OF THE PANCREAS

NEXIUM INTRAVENOUS esomeprazole sodium


EXOCRINE: 93% Acinar Cells Duct Cells. ENDOCRINE: 5% Alpha Cells Beta Cells Delta Cells Others

Objectives. Terminology 03/11/2013. Pitfalls in the diagnosis of Gastroenteropancreatic Neuroendocrine Tumors. Pathology Update 2013

Final stages of colon cancer what to expect

The Players. Liver Thyroid Adrenals Pancreas Reproductive System Pituitary Gut Bacteria

Case Scenario 1. Discharge Summary

Human Body. The student knows that the human body is made of systems with structure and functions that are related.

Sometimes it takes a couple of years to find the right diagnoses. Norway, Medha Sharma and Asha Sundaran

OUTLINE OUTLINE 25/04/2018. Massimo Milione MD, PhD. General Features and Classifications. Ki67 role?

The London Gastroenterology Partnership CROHN S DISEASE

Endocrine System Objectives

Eloxatin Oxaliplatin concentrated solution for injection

Pancreatic Cancer. What is pancreatic cancer?

Grade 2 Ileum NET with liver and bone metastasis

Digestive System Module 6: Accessory Organs in Digestion: The Liver, Pancreas, and Gallbladder

Transcription:

Pathology testing and Neuroendocrine tumours (NETs)

NETs are probably far more common than we think. Most grow so slowly and produce such widely varied and non-specific symptoms, or no symptoms at all, that it is not unusual for someone to have spent years seeking answers to their health problems before a diagnosis is made.

NEUROENDOCRINE TUMOURS (NETs) NETs are relatively uncommon tumours that develop from neuroendocrine cells. These cells are present in many organs throughout the body and their job is to release hormones chemical messengers that regulate bodily functions. There are several different types of NET depending on where they occur. However, they all share similar cellular characteristics that can be seen under the microscope. NETs can be benign or malignant. Most arise in the digestive system, including the bowel, appendix, pancreas and stomach and are referred to as gastroenteropancreatic neuroendocrine tumours (GEP NETs). They can also develop in the lungs; the better known include small-cell lung cancer, large-cell neuroendocrine carcinoma, and typical or atypical carcinoid tumours. Very rarely, they form in other organs such as the liver, gallbladder, bile ducts, kidneys, ovaries or testicles. The largest sub-group of NETs are carcinoids, which account for more than half of those diagnosed. NETs are uncommon and also underdiagnosed. They can overproduce hormones such as serotonin, insulin, gastrin and catecholamines. This can be continuous or intermittent and lead to symptoms and syndromes (groups of symptoms) that can be characteristic of the particular NET. Symptoms are often vague and nonspecific and vary widely according to the type, size and location of the tumour(s). Common symptoms include diarrhoea, flushing of the skin, wheezing, weight loss, anaemia, low blood sugar (headaches, confusion), stomach cramps and occasionally skin rash. Some NETS do not produce hormones and cause minimal symptoms. These are referred to as non-functioning NETs.

DIFFICULTIES IN DIAGNOSIS Because NETs are generally slow-growing, and any symptoms they produce are varied and non-specific, they can be notoriously difficult to diagnose. NETs often present a diagnostic challenge for doctors. It is not unusual for someone with a NET to have spent years seeking answers to their health problems before a diagnosis is made. PATHOLOGY TESTS Your doctor may start by referring you for some blood and urine tests called tumour markers. These are substances such as proteins and hormones in the blood and urine that are known to increase when certain tumours are present. Although they cannot be relied upon alone to identify a particular tumour, these markers are very useful in confirming a diagnosis in someone strongly suspected of having a tumour. They are also important in monitoring for tumour recurrence or progression after treatment. Chromogranin A (CgA) CgA is a protein released by neuroendocrine cells and is seen in increased amounts in the blood of most people with NETs. CgA is especially useful because it is also elevated by non-functioning NETs. This means CgA is one of the most widely used markers for NETs. Serum CgA levels are also elevated by the use of proton pump inhibitors (PPIs), used for gastrooesophageal reflux or peptic ulcers. These must be stopped for at least two weeks before the blood sample is collected. Platelet serotonin Most of the serotonin in the blood stream is stored in platelets. This blood test is often used in combination with CgA and 5-HIAA.

5-Hydroxyindoleacetic acid (5-HIAA) Serotonin is broken down by the liver into a chemical called 5-HIAA and then passed out of the body in the urine. A urine test detects raised 5-HIAA levels. Because serotonin may be secreted intermittently, a 24-hour urine collection is needed. Serotonin-rich foods such as bananas, avocadoes, tomatoes, pineapples and nuts can cause temporary elevations of 5-HIAA and should be avoided for at least three days before the test. Some medications and other health conditions can affect 5-HIAA levels and need to be discussed with your doctor. Hormones As well as CgA, 5-HIAA and platelet serotonin, pathology tests may be used to find out if you have increased blood levels of particular hormones. These include insulin, gastrin, pancreatic polypeptide (PP) vasoactive intestinal peptide (VIP) and glucagon. Microscopic investigation (histology) By examining a sample under the microscope the pathologist can identify the precise type of tumour and assess how advanced it is so that treatment decisions can be made. This requires surgery and/or a biopsy to obtain the sample. Observing a sample of the tumour microscopically provides the only definitive diagnosis of a NET

How can I have tests for NETs? Pathology is a medical specialty, so your doctor will need to complete a pathology request form to refer you for tests. Are there any special things I have to do? Because hormones may be released only intermittently by NETS, some samples for hormone tests may need to be collected when symptoms are present. Your doctor will advise you on this. The fasting blood tests and the 5-HIAA 24-hour urine test may also have special conditions attached. Your doctor or pathology collector can advise you. Where can I have my test collected? Locate our collection centres For a full list of collection centres and their opening hours, visit snp.com.au. With your webenabled camera, phone-scan the QR code with a QR code reader application. SULLIVAN NICOLAIDES PTY LTD ABN 38 078 202 196 A subsidiary of Sonic Healthcare Limited ABN 24 004 196 909 134 WHITMORE STREET TARINGA QLD 4068 AUSTRALIA TEL (07) 3377 8666 FAX (07) 3870 0549 P O BOX 344 INDOOROOPILLY QLD 4068 AUSTRALIA www.snp.com.au Item 10954 October 2013 Sullivan Nicolaides Pty Ltd 2013